Cargando…
Adriamycin cardiotoxicity monitoring by radionuclide scan.
Autores principales: | Robinson, B. A., Colls, B. M., Turner, J. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011444/ https://www.ncbi.nlm.nih.gov/pubmed/6882671 |
Ejemplares similares
-
Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986) -
Protective effect of melatonin against Adriamycin-induced cardiotoxicity
por: ZHANG, YAN, et al.
Publicado: (2013) -
Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
por: Zhu, Hong, et al.
Publicado: (2014) -
Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity
por: Liang, Zhenxing, et al.
Publicado: (2021) -
Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy
por: Jones, K. A., et al.
Publicado: (2020)